Insider Transactions in Q4 2021 at Jounce Therapeutics, Inc. (JNCE)

JNCE Quotes by TradingView

Insider Transaction List (Q4 2021)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Nov 12 2021
Cary Pfeffer Director
SELL
Open market or private sale
Indirect
0
-
Nov 12 2021
Third Rock Ventures Iii, L.P. > 10% Shareholder
SELL
Open market or private sale
Direct
1,900,000 -62.32%
$15,200,000 $8.38 P/Share

Track Institutional and Insider Activities on JNCE

Follow Jounce Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

News

Receive news related to Jounce Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNCE